Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies88

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies43

Views

Views
May 20250
June 20250
July 202527
August 20250
September 202511
October 20253
November 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil16
United States12
United Kingdom4
Hong Kong2
Ecuador2
Argentina1
Germany1
Spain1
Morocco1
Mexico1
 

Top cities views

Views
Dallas5
Rio de Janeiro2
São Paulo2
Hong Kong2
Ambato1
Baltimore1
Cape Town1
Dayton1
Diadema1
Encarnación1